{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T21:12:44Z","timestamp":1789074764967,"version":"build-2803163510"},"reference-count":17,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T00:00:00Z","timestamp":1786147200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003593","name":"National Council for Scientific and Technological Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004586","name":"Carlos Chagas Filho Foundation for Research Support of Rio de Janeiro State","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004586","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hematology, Transfusion and Cell Therapy"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.htct.2026.106531","type":"journal-article","created":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T03:55:27Z","timestamp":1788666927000},"page":"106531","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Real-world outcomes of CD34\u207a mobilization and early autologous hematopoietic stem cell transplantation recovery after daratumumab-based induction"],"prefix":"10.1016","volume":"48","author":[{"given":"Arthur Sousa","family":"dos Anjos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio Verti","family":"Mendon\u00e7a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone Cunha","family":"Maradei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliana Pessoa Rivello","family":"de Azevedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Kaufman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8376-7199","authenticated-orcid":false,"given":"Maria Claudia","family":"Moreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5178-4536","authenticated-orcid":false,"given":"Monique","family":"Morgado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1067-6680","authenticated-orcid":false,"given":"Marcia","family":"Garnica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0140-9548","authenticated-orcid":false,"given":"Angelo","family":"Maiolino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.htct.2026.106531_bib0001","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1001\/jama.2022.0003","article-title":"Diagnosis and management of multiple myeloma: a review","volume":"327","author":"Cowan","year":"2022","journal-title":"JAMA"},{"issue":"10272","key":"10.1016\/j.htct.2026.106531_bib0002","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/S0140-6736(21)00135-5","article-title":"Multiple myeloma","volume":"397","author":"Van De Donk","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.htct.2026.106531_bib0003","doi-asserted-by":"crossref","unstructured":"Moreau P., Attal M., Hulin C., Arnulf B., Belhadj K., Benboubker L., et al. Bortezomib, thalidomide, and dexamethasone with or without daratumumab before and after autologous stem cell transplantation for newly diagnosed multiple myeloma (CASSIOPEIA): a randomised, open-label, phase 3 study. Lancet. 2019;394(10192):29\u201338. doi: 10.1016\/S0140-6736(19)31240-1. Epub 2019 Jun 3. Erratum in: Lancet. 2024 Aug 31;404(10455):e3. doi: 10.1016\/S0140-6736(19)31403-5 PMID: 31171419.","DOI":"10.1016\/S0140-6736(19)31403-5"},{"issue":"4","key":"10.1016\/j.htct.2026.106531_bib0004","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1056\/NEJMoa2312054","article-title":"PERSEUS trial investigators. Daratumumab, bortezomib, lenalidomide, and dexamethasone for multiple myeloma","volume":"390","author":"Sonneveld","year":"2024","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.htct.2026.106531_bib0005","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/S1470-2045(24)00282-1","article-title":"Bortezomib, thalidomide, and dexamethasone with or without daratumumab and followed by daratumumab maintenance or observation in transplant-eligible newly diagnosed multiple myeloma: long-term follow-up of the CASSIOPEIA randomised controlled phase 3 trial","volume":"25","author":"Moreau","year":"2024","journal-title":"Lancet Oncol"},{"issue":"2","key":"10.1016\/j.htct.2026.106531_bib0006","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1056\/NEJMoa2204925","article-title":"Triplet therapy, transplantation, and maintenance until progression in myeloma","volume":"387","author":"Richardson","year":"2022","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.htct.2026.106531_bib0007","first-page":"174.e1","article-title":"Stem cell mobilization yields with daratumumab- and lenalidomide-containing quadruplet induction therapy in newly diagnosed multiple myeloma: findings from the MASTER and GRIFFIN trials","volume":"29","author":"Chhabra","year":"2023","journal-title":"Transpl Cell Ther"},{"issue":"7","key":"10.1016\/j.htct.2026.106531_bib0008","doi-asserted-by":"crossref","first-page":"944","DOI":"10.3390\/ph17070944","article-title":"Impact of Anti-CD38 monoclonal antibody therapy on CD34+ hematopoietic stem cell mobilization, collection, and engraftment in multiple myeloma patients-a systematic review","volume":"17","author":"Bigi","year":"2024","journal-title":"Pharmaceuticals"},{"issue":"13","key":"10.1016\/j.htct.2026.106531_bib0009","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1080\/10428194.2023.2253479","article-title":"Impact of daratumumab on stem cell mobilization and collection, engraftment and early post-transplant complications among multiple myeloma patients undergoing autologous stem cell transplantation","volume":"64","author":"Eleutherakis Papaiakovou","year":"2023","journal-title":"Leuk Lymphoma"},{"issue":"19","key":"10.1016\/j.htct.2026.106531_bib0010","doi-asserted-by":"crossref","first-page":"3307","DOI":"10.3390\/cancers16193307","article-title":"First-line use of daratumumab in patients with multiple myeloma shows delayed neutrophil and platelet engraftment after autologous stem cell transplantation: results from a real-life single-center study","volume":"16","author":"Martino","year":"2024","journal-title":"Cancers"},{"issue":"5","key":"10.1016\/j.htct.2026.106531_bib0011","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/sj.bmt.1703855","article-title":"Engraftment syndrome following autologous hematopoietic stem cell transplantation: definition of diagnostic criteria","volume":"31","author":"Maiolino","year":"2003","journal-title":"Bone Marrow Transpl"},{"issue":"8","key":"10.1016\/j.htct.2026.106531_bib0012","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.3324\/haematol.2020.261842","article-title":"Stem cell yield and transplantation in transplant-eligible newly diagnosed multiple myeloma patients receiving daratumumab + bortezomib\/thalidomide\/dexamethasone in the phase 3 CASSIOPEIA study","volume":"106","author":"Hulin","year":"2021","journal-title":"Haematologica"},{"issue":"4","key":"10.1016\/j.htct.2026.106531_bib0013","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.3324\/haematol.2025.288411","article-title":"The impact of daratumumab-containing induction on stem cell mobilization, collection and engraftment in newly diagnosed multiple myeloma: results of the prospective DILEMMA study","volume":"111","author":"Valentini","year":"2026","journal-title":"Haematologica"},{"issue":"10","key":"10.1016\/j.htct.2026.106531_bib0014","doi-asserted-by":"crossref","first-page":"5371","DOI":"10.1007\/s00277-025-06581-x","article-title":"Impact of Dara-VTd induction therapy on stem cell mobilization outcomes in newly diagnosed multiple myeloma patients undergoing autologous stem cell transplantation: a multicenter study","volume":"104","author":"Della Pepa","year":"2025","journal-title":"Ann Hematol"},{"issue":"10","key":"10.1016\/j.htct.2026.106531_bib0015","doi-asserted-by":"crossref","first-page":"4345","DOI":"10.1007\/s00277-024-05933-3","volume":"103","author":"Strafella","year":"2024","journal-title":"Ann Hematol"},{"issue":"8","key":"10.1016\/j.htct.2026.106531_bib0016","doi-asserted-by":"crossref","first-page":"e563","DOI":"10.1016\/j.clml.2025.04.003","article-title":"Stem cell mobilization yields with daratumumab (dara) and lenalidomide (len)-containing quadruplet induction therapy in patients with newly diagnosed multiple myeloma (NDMM): a real-world experience at 2 institutes","volume":"25","author":"Varga","year":"2025","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"5","key":"10.1016\/j.htct.2026.106531_bib0017","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1038\/s41409-025-02558-6","article-title":"Impact of daratumumab on the development of engraftment syndrome after autologous peripheral blood stem cell transplantation for multiple myeloma","volume":"60","author":"Minakata","year":"2025","journal-title":"Bone Marrow Transpl"}],"container-title":["Hematology, Transfusion and Cell Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2531137926002786?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2531137926002786?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T20:55:07Z","timestamp":1789073707000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2531137926002786"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":17,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S2531137926002786"],"URL":"https:\/\/doi.org\/10.1016\/j.htct.2026.106531","relation":{},"ISSN":["2531-1379"],"issn-type":[{"value":"2531-1379","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Real-world outcomes of CD34\u207a mobilization and early autologous hematopoietic stem cell transplantation recovery after daratumumab-based induction","name":"articletitle","label":"Article Title"},{"value":"Hematology, Transfusion and Cell Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.htct.2026.106531","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Associa\u00e7\u00e3o Brasileira de Hematologia, Hemoterapia e Terapia Celular. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"106531"}}